Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, Allakos (ALLK) has a market cap of $0.10 billion USD. According to our data, Allakos is ranked No.7691 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 22, 2025 | $0.10 B |
-7.44%
|
| Dec 31, 2024 | $0.11 B |
-55.68%
|
| Dec 29, 2023 | $0.24 B |
-67.58%
|
| Dec 30, 2022 | $0.75 B |
-13.99%
|
| Dec 31, 2021 | $0.87 B |
-93.01%
|
| Dec 31, 2020 | $12.51 B |
46.81%
|
| Dec 31, 2019 | $8.52 B |
82.44%
|
| Dec 31, 2018 | $4.67 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Genmab
GMAB
|
$13.32 B |
0.000 M
|
Denmark
|
 Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
 Blueprint Medicines
BPMC
|
$7.06 B |
-0.000 M
|
USA
|
 Deciphera Pharmaceuticals
DCPH
|
$2.21 B |
2.213 B
|
USA
|
 Kiniksa Pharmaceuticals
KNSA
|
$1.39 B |
0.588 B
|
|
 TG Therapeutics
TGTX
|
$4.54 B |
0.000 M
|
USA
|
 Sutro Biopharma
STRO
|
$0.16 B |
-0.000 M
|
USA
|
 Gossamer Bio
GOSS
|
$0.20 B |
0.000 M
|
USA
|
 Immunic
IMUX
|
$88.60 M |
-0.000 M
|
USA
|
 Alector
ALEC
|
$0.17 B |
0.000 M
|
USA
|
 Vir Biotechnology
VIR
|
$1.45 B |
0.000 M
|
USA
|
 Atara Biotherapeutics
ATRA
|
$39.68 M |
0.000 M
|
USA
|
 Apellis Pharmaceuticals
APLS
|
$3.78 B |
-0.000 M
|
USA
|
| Market Cap | = | ALLK Stock Price | * | ALLK Shares Outstanding |
| = | $1.12 | * | 89.34 M | |
| = | $0.10 B |